| Use of machine learning approaches for novel drug discovery AN Lima, EA Philot, GHG Trossini, LPB Scott, VG Maltarollo, KM Honorio Expert opinion on drug discovery 11 (3), 225-239, 2016 | 244 | 2016 |
| Nitric oxide: state of the art in drug design RAM Serafim, MC Primi, GHG Trossini, EI Ferreira Current medicinal chemistry 19 (3), 386-405, 2012 | 110 | 2012 |
| Design and synthesis of new (E)-cinnamic N-acylhydrazones as potent antitrypanosomal agents SA Carvalho, LO Feitosa, M Soares, TEMM Costa, MG Henriques, ... European journal of medicinal chemistry 54, 512-521, 2012 | 88 | 2012 |
| Quantitative structure–activity relationships for a series of inhibitors of cruzain from Trypanosoma cruzi: Molecular modeling, CoMFA and CoMSIA studies GHG Trossini, RVC Guido, G Oliva, EI Ferreira, AD Andricopulo Journal of Molecular Graphics and Modelling 28 (1), 3-11, 2009 | 72 | 2009 |
| Design, synthesis and biological evaluation of new aryl thiosemicarbazone as antichagasic candidates L Blau, RF Menegon, GHG Trossini, JVD Molino, DG Vital, RMB Cicarelli, ... European Journal of Medicinal Chemistry 67, 142-151, 2013 | 50 | 2013 |
| Structure-activity relationships for a class of selective inhibitors of the major cysteine protease from Trypanosoma cruzi RVC Guido, GHG Trossini, MS Castilho, G Oliva, EI Ferreira, ... Journal of Enzyme Inhibition and Medicinal Chemistry 23 (6), 964-973, 2008 | 42 | 2008 |
| Pharmacological Evaluation and Preparation of Nonsteroidal Anti-Inflammatory Drugs Containing an N-Acyl Hydrazone Subunit TRF De Melo, RC Chelucci, MEL Pires, LA Dutra, KP Barbieri, ... International journal of molecular sciences 15 (4), 5821-5837, 2014 | 39 | 2014 |
| Enantioselective Arylations Catalyzed by Carbohydrate‐Based Chiral Amino Alcohols AD Wouters, GHG Trossini, HA Stefani, DS Lüdtke European Journal of Organic Chemistry 2010 (12), 2351-2356, 2010 | 32 | 2010 |
| Theoretical study of tautomers and photoisomers of avobenzone by DFT methods GHG Trossini, VG Maltarollo, RDA Garcia, CASO Pinto, MVR Velasco, ... Journal of molecular modeling 21, 1-7, 2015 | 30 | 2015 |
| Cruzain inhibition by hydroxymethylnitrofurazone and nitrofurazone: investigation of a new target in Trypanosoma cruzi GHG Trossini, A Malvezzi, A T.-do Amaral, CO Rangel-Yagui, MA Izidoro, ... Journal of enzyme inhibition and medicinal chemistry 25 (1), 62-67, 2010 | 30 | 2010 |
| An integrated approach towards the discovery of novel non-nucleoside Leishmania major pteridine reductase 1 inhibitors FHA Leite, TQ Froes, SG da Silva, EIM de Souza, DG Vital-Fujii, ... European journal of medicinal chemistry 132, 322-332, 2017 | 27 | 2017 |
| The anti-inflammatory and immunomodulatory potential of braylin: Pharmacological properties and mechanisms by in silico, in vitro and in vivo approaches RF Espirito-Santo, CS Meira, RS Costa, OP Souza Filho, AF Evangelista, ... PLoS One 12 (6), e0179174, 2017 | 26 | 2017 |
| Characterization and Short-Term clinical study of clay facial mask MVR Velasco, V Zague, MF Dario, DO Nishikawa, CASO Pinto, ... Revista de Ciencias Farmaceuticas Basica e Aplicada 37 (1), 2016 | 26 | 2016 |
| Benchmark studies of UV–vis spectra simulation for cinnamates with UV filter profile RDA Garcia, VG Maltarollo, KM Honório, GHG Trossini Journal of Molecular Modeling 21, 1-13, 2015 | 25 | 2015 |
| New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches R V Bueno, R C Braga, N D Segretti, E I Ferreira, G HG Trossini, ... Current Pharmaceutical Design 20 (27), 4474-4485, 2014 | 24 | 2014 |
| Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses T Kronenberger, LR Asse Jr, C Wrenger, GHG Trossini, KM Honorio, ... Future medicinal chemistry 9 (2), 135-151, 2017 | 23 | 2017 |
| Hologram QSAR studies of antiprotozoal activities of sesquiterpene lactones GHG Trossini, VG Maltarollo, TJ Schmidt Molecules 19 (7), 10546-10562, 2014 | 22 | 2014 |
| Caracterização físico-química de complexo de inclusão entre hidroximetilnitrofurazona e hidroxipropil-beta-ciclodextrina R Grillo, NFS de Melo, LF Fraceto, CL Brito, GHG Trossini, C Menezes, ... Química nova 31, 290-295, 2008 | 22 | 2008 |
| Fragment‐based drug discovery as alternative strategy to the drug development for neglected diseases JFR Mello, RA Gomes, DG Vital‐Fujii, GM Ferreira, GHG Trossini Chemical biology & drug design 90 (6), 1067-1078, 2017 | 21 | 2017 |
| Advances and challenges in drug design of PPARδ ligands VG Maltarollo, T Kronenberger, B Windshugel, C Wrenger, GHG Trossini, ... Current Drug Targets 19 (2), 144-154, 2018 | 20 | 2018 |
